药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tolazamide
Tucidinostat
The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Tucidinostat.
Tolazamide
Tedisamil
The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Tedisamil.
Tolazamide
Garenoxacin
The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Garenoxacin.
Tolazamide
Technetium Tc-99m ciprofloxacin
The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Technetium Tc-99m ciprofloxacin.
Tolazamide
Pracinostat
The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Pracinostat.
Tolazamide
Lofexidine
The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Lofexidine.
Tolazamide
Terlipressin
The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Terlipressin.
Tolazamide
Aceprometazine
The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Aceprometazine.
Tolazamide
Probucol
The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Probucol.
Tolazamide
Oxprenolol
The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Oxprenolol.
Tolazamide
Gemifloxacin
The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Saquinavir.
Tolazamide
Papaverine
The risk or severity of QTc prolongation can be increased when Papaverine is combined with Saquinavir.
Tolazamide
Dimenhydrinate
The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Saquinavir.
Tolazamide
Mesoridazine
The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Saquinavir.
Tolazamide
Levosimendan
The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Saquinavir.
Tolazamide
Lumefantrine
The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Lumefantrine.
Tolazamide
Terodiline
The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Terodiline.
Tolazamide
Macimorelin
The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Macimorelin.
Tolazamide
Glasdegib
The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Saquinavir.
Tolazamide
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Tetrabenazine.